Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia?

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	1987

Schlagwörter:	Adverse Effect High Risk Pneumonia High Risk Patient Pleural Effusion

Anmerkung:	© Adis International Ltd 1987

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 582(1987), 1 vom: Apr., Seite 11-12
Übergeordnetes Werk:	volume:582 ; year:1987 ; number:1 ; month:04 ; pages:11-12

Links:	Volltext

DOI / URN:	10.1007/BF03305824

Katalog-ID:	SPR03593218X

Internformat


LEADER	01000caa a22002652 4500
001	SPR03593218X
003	DE-627
005	20230519161145.0
007	cr uuu---uuuuu
008	201007s1987 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/BF03305824 \|2 doi
035			\|a (DE-627)SPR03593218X
035			\|a (SPR)BF03305824-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia?
264		1	\|c 1987
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 1987
650		4	\|a Adverse Effect \|7 (dpeaa)DE-He213
650		4	\|a High Risk \|7 (dpeaa)DE-He213
650		4	\|a Pneumonia \|7 (dpeaa)DE-He213
650		4	\|a High Risk Patient \|7 (dpeaa)DE-He213
650		4	\|a Pleural Effusion \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 582(1987), 1 vom: Apr., Seite 11-12 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:582 \|g year:1987 \|g number:1 \|g month:04 \|g pages:11-12
856	4	0	\|u https://dx.doi.org/10.1007/BF03305824 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 582 \|j 1987 \|e 1 \|c 04 \|h 11-12

Indexfelder

matchkey_str	article:22306056:1987----::etzxmcftxmoltmxf
hierarchy_sort_str	1987
publishDate	1987
allfields	10.1007/BF03305824 doi (DE-627)SPR03593218X (SPR)BF03305824-e DE-627 ger DE-627 rakwb eng Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia? 1987 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1987 Adverse Effect (dpeaa)DE-He213 High Risk (dpeaa)DE-He213 Pneumonia (dpeaa)DE-He213 High Risk Patient (dpeaa)DE-He213 Pleural Effusion (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 582(1987), 1 vom: Apr., Seite 11-12 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:582 year:1987 number:1 month:04 pages:11-12 https://dx.doi.org/10.1007/BF03305824 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 582 1987 1 04 11-12
spelling	10.1007/BF03305824 doi (DE-627)SPR03593218X (SPR)BF03305824-e DE-627 ger DE-627 rakwb eng Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia? 1987 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1987 Adverse Effect (dpeaa)DE-He213 High Risk (dpeaa)DE-He213 Pneumonia (dpeaa)DE-He213 High Risk Patient (dpeaa)DE-He213 Pleural Effusion (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 582(1987), 1 vom: Apr., Seite 11-12 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:582 year:1987 number:1 month:04 pages:11-12 https://dx.doi.org/10.1007/BF03305824 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 582 1987 1 04 11-12
allfields_unstemmed	10.1007/BF03305824 doi (DE-627)SPR03593218X (SPR)BF03305824-e DE-627 ger DE-627 rakwb eng Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia? 1987 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1987 Adverse Effect (dpeaa)DE-He213 High Risk (dpeaa)DE-He213 Pneumonia (dpeaa)DE-He213 High Risk Patient (dpeaa)DE-He213 Pleural Effusion (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 582(1987), 1 vom: Apr., Seite 11-12 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:582 year:1987 number:1 month:04 pages:11-12 https://dx.doi.org/10.1007/BF03305824 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 582 1987 1 04 11-12
allfieldsGer	10.1007/BF03305824 doi (DE-627)SPR03593218X (SPR)BF03305824-e DE-627 ger DE-627 rakwb eng Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia? 1987 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1987 Adverse Effect (dpeaa)DE-He213 High Risk (dpeaa)DE-He213 Pneumonia (dpeaa)DE-He213 High Risk Patient (dpeaa)DE-He213 Pleural Effusion (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 582(1987), 1 vom: Apr., Seite 11-12 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:582 year:1987 number:1 month:04 pages:11-12 https://dx.doi.org/10.1007/BF03305824 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 582 1987 1 04 11-12
allfieldsSound	10.1007/BF03305824 doi (DE-627)SPR03593218X (SPR)BF03305824-e DE-627 ger DE-627 rakwb eng Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia? 1987 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1987 Adverse Effect (dpeaa)DE-He213 High Risk (dpeaa)DE-He213 Pneumonia (dpeaa)DE-He213 High Risk Patient (dpeaa)DE-He213 Pleural Effusion (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 582(1987), 1 vom: Apr., Seite 11-12 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:582 year:1987 number:1 month:04 pages:11-12 https://dx.doi.org/10.1007/BF03305824 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 582 1987 1 04 11-12
language	English
source	Enthalten in Inpharma weekly 582(1987), 1 vom: Apr., Seite 11-12 volume:582 year:1987 number:1 month:04 pages:11-12
sourceStr	Enthalten in Inpharma weekly 582(1987), 1 vom: Apr., Seite 11-12 volume:582 year:1987 number:1 month:04 pages:11-12
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Adverse Effect High Risk Pneumonia High Risk Patient Pleural Effusion
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	1987-04-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR03593218X
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03593218X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519161145.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1987 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/BF03305824</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03593218X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)BF03305824-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1987</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1987</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adverse Effect</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">High Risk</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pneumonia</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">High Risk Patient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pleural Effusion</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">582(1987), 1 vom: Apr., Seite 11-12</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:582</subfield><subfield code="g">year:1987</subfield><subfield code="g">number:1</subfield><subfield code="g">month:04</subfield><subfield code="g">pages:11-12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/BF03305824</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">582</subfield><subfield code="j">1987</subfield><subfield code="e">1</subfield><subfield code="c">04</subfield><subfield code="h">11-12</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia? Adverse Effect (dpeaa)DE-He213 High Risk (dpeaa)DE-He213 Pneumonia (dpeaa)DE-He213 High Risk Patient (dpeaa)DE-He213 Pleural Effusion (dpeaa)DE-He213
topic	misc Adverse Effect misc High Risk misc Pneumonia misc High Risk Patient misc Pleural Effusion
spellingShingle	misc Adverse Effect misc High Risk misc Pneumonia misc High Risk Patient misc Pleural Effusion Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia?
topic_unstemmed	misc Adverse Effect misc High Risk misc Pneumonia misc High Risk Patient misc Pleural Effusion
topic_browse	misc Adverse Effect misc High Risk misc Pneumonia misc High Risk Patient misc Pleural Effusion
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia?
ctrlnum	(DE-627)SPR03593218X (SPR)BF03305824-e
title_full	Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia?
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	1987
contenttype_str_mv	txt
container_start_page	11
container_volume	582
format_se	Elektronische Aufsätze
doi_str_mv	10.1007/BF03305824
title_sort	ceftizoxime, cefotaxime or latamoxef for pneumonia?
title_auth	Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia?
abstract	© Adis International Ltd 1987
abstractGer	© Adis International Ltd 1987
abstract_unstemmed	© Adis International Ltd 1987
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia?
url	https://dx.doi.org/10.1007/BF03305824
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.1007/BF03305824
up_date	2024-07-03T16:09:15.744Z
_version_	1803574790843269120
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR03593218X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519161145.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1987 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/BF03305824</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR03593218X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)BF03305824-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia?</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1987</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1987</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Adverse Effect</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">High Risk</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pneumonia</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">High Risk Patient</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pleural Effusion</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">582(1987), 1 vom: Apr., Seite 11-12</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:582</subfield><subfield code="g">year:1987</subfield><subfield code="g">number:1</subfield><subfield code="g">month:04</subfield><subfield code="g">pages:11-12</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/BF03305824</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">582</subfield><subfield code="j">1987</subfield><subfield code="e">1</subfield><subfield code="c">04</subfield><subfield code="h">11-12</subfield></datafield></record></collection>
score	7.401725

Nicht das Richtige dabei?

Schreiben Sie uns!

Ceftizoxime, Cefotaxime or Latamoxef for Pneumonia?

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?